Dominican Republic vs Guam: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Dominican Republic
0.1%
in 2024
Guam
0.1%
in 2024
Dominican Republic rank
134th
Guam rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Dominican Republic
- Guam
How they compare
Dominican Republic currently reports 0.1% against 0.1% in Guam, a difference of 0.0%.
Across all 10 years both countries report, Guam has been ahead every year.
Dominican Republic ranks 134th and Guam ranks 134th of 246 countries.
Guam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Guam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.5% | 0.3% | Guam |
| 2020s | 0.1% | 0.2% | 0.1% | Guam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Dominican Republic or Guam?
- Dominican Republic, at 0.1% against 0.1% in Guam as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Dominican Republic and Guam?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Guam?
- 10 years are reported by both, from 2015 to 2024.
- How do Dominican Republic and Guam rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Dominican Republic ranks 134th and Guam ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.